Lyvgen and BMS partner for Phase II lung cancer antibody trial

Lyvgen and BMS partner for Phase II lung cancer antibody trial

Submitted by admin on November 28, 2022 - 10:18am
Source: 
Clinical Trials Arena
News Tags: 
Lyvgen
Bristol Myers Squibb
clinical trials
LVGN7409
non-small cell lung cancer
Headline: 
Lyvgen and BMS partner for Phase II lung cancer antibody trial
snippet: 

Lyvgen Biopharma has partnered with Bristol Myers Squibb (BMS ) to carry out a Phase II clinical trial of the former’s antibody, LVGN7409, plus docetaxel or nivolumab in advanced/metastatic non-small cell lung cancer (NSCLC) patients.

Do Not Allow Advertisers to Use My Personal information